HealthDay on MSN8h
Molecular Residual Disease Analysis May Predict Disease Recurrence After Lung Cancer Resection
For patients with resected stage IB-IIIA epidermal growth factor receptor-mutated non-small cell lung cancer, molecular ...
Medscape18d
AML: Monitor Early Measurable Residual Disease to Optimize Outcomes
Early clearance of measurable residual disease (MRD) after induction therapy in patients with acute myeloid leukemia (AML) is associated with significantly better relapse-free survival (RFS ...